Gentamycin Market to grow at a formidable rate Until FY2026
Growing prevalence of
bacterial infections is expected to drive the growth of India gentamycin
market.
According
to TechSci Research report, “India Gentamycin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Eye Drops, Tablet, Capsule,
Syrup, Injection, Cream, Gel, Ointment, Others), By Route of Administration
(Ophthalmic, Intravenous, Topical, Oral, Others), By Distribution Channel
(Online v/s Offline), By Application (Bacterial Infection, Urinary Tract
Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory
Tract Infection, Others), By Company, By Region, Forecast & Opportunities,
FY2026”, the India gentamycin market
is expected to grow at a steady rate during the forecast period on account of the
widespread use of the drug in treatment of meningitis, cystic fibrosis, pelvic
respiratory diseases, plague, pneumonia, conjunctivitis, among others. Additionally,
availability in different forms ranging from capsules, tablet, syrup, gel,
ointments, among others are further expected to fuel the market growth through
FY2026. Furthermore, the drug is even used as second line of treatment against
bacteria having resistance towards any particular antibiotic. This in turn is
expected to propel the market growth over the next few years. Also, the drug is
present in the WHO’s list of essential medicine, thereby increasing the demand
for the antibiotics and fostering the market growth during the forecast period.
However, inner ear problems and kidney problems are the most commonly observed
side effects observed due to consumption of gentamycin. This in turn is
expected to restrict the market growth over the next five years.
Browse XX market data Tables and XX
Figures spread through XXX
Pages and an in-depth TOC on" India Gentamycin Market "
https://www.techsciresearch.com/report/india-gentamycin-market/5167.html
The India gentamycin market is segmented based on source, form, route of
administration, distribution channel, application, company and region. Based on
source, the market can be split into in-house and contract manufacturing
organizations. The contract manufacturing organizations segment is expected to
register significant growth in the market through FY2026. This can be ascribed
to the fact that various pharmaceutical companies have started outsourcing the
production of several drugs and APIs to these organizations so that they can
focus on research and development of new drugs and their expansion.
Additionally, these organizations have the capability of manufacturing even
large quantities of the formulations depending upon the client requirement in a
shorter duration of time and at a very competitive price. Based on form, the
market can be categorized into eye drops, tablet, capsule, syrup, injection,
cream, gel, ointment and others. The tablet segment is expected to dominate the
market since it can accommodate a large amount of API as compared to the other
counterparts. While capsule segment is expected to register the highest growth
during the forecast period on account of the associated benefits such as fast
action, tamper resistance, higher rate of absorption, among others. Based on
distribution channel, the market can be split into online and offline. The
offline channel is expected to dominate the market owing to the consumer
preference for buying medicines from a pharmacy or drug store. The online
segment is also expected to register significant growth over the next few
years. This can be ascribed to the emergence of several online pharmacies,
digital platforms and doorstep drug delivery e-commerce platforms in the
country.
Taj Pharmaceuticals Ltd., Bayer India Ltd., Zydus Cadila Healthcare
Ltd., Neon Laboratories Ltd., Hetero Healthcare Ltd., Gracure Pharmaceuticals
Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Fresenius Kabi
India Pvt. Ltd., Nestor Pharmaceuticals Ltd. and others are some of the leading
players operating in India gentamycin market. Companies operating in the market
are using organic strategies such as product launches, mergers and
collaborations to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5167
Customers can also
request for 10% free customization on this report.
“India gentamycin market is expected to
witness growth during the forecast period on account of the growing prevalence
of diabetes in the country. India is the country with second highest diabetic
population in the world and gentamycin is also being used as an anti-diabetic
drug thereby driving the market growth. Additionally, the widespread use of the
antibiotic for treatment of a wide range of bacterial infections is further
expected to spur the market growth through FY2026.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Gentamycin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Eye Drops, Tablet, Capsule,
Syrup, Injection, Cream, Gel, Ointment, Others), By Route of Administration
(Ophthalmic, Intravenous, Topical, Oral, Others), By Distribution Channel
(Online v/s Offline), By Application (Bacterial Infection, Urinary Tract
Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory
Tract Infection, Others), By Company, By Region, Forecast & Opportunities,
FY2026”, has
evaluated the future growth potential of India gentamycin market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India gentamycin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]